Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1966 Apr;59(4):287–292. doi: 10.1177/003591576605900401

Uric acid production with particular reference to the role of xanthine oxidase and its inhibition.

R W Watts
PMCID: PMC1900614  PMID: 5937675

Full text

PDF
287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AYVAZIAN J. H. XANTHINURIA AND HEMOCHROMATOSIS. N Engl J Med. 1964 Jan 2;270:18–22. doi: 10.1056/NEJM196401022700104. [DOI] [PubMed] [Google Scholar]
  2. BAILIE M. J., MORTON R. K. Comparative properties of microsomes from cow's milk and from mammary gland. 1. Enzymic activities. Biochem J. 1958 May;69(1):35–44. doi: 10.1042/bj0690035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BERGMANN F., DIKSTEIN S. Studies on uric acid and related compounds. III. Observations on the specificity of mammalian xanthine oxidases. J Biol Chem. 1956 Dec;223(2):765–780. [PubMed] [Google Scholar]
  4. BLAIR J. A. Isolation of isoxanthopterin from human urine. Biochem J. 1958 Mar;68(3):385–387. doi: 10.1042/bj0680385a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Booth V. H. The specificity of xanthine oxidase. Biochem J. 1938 Mar;32(3):494–502. doi: 10.1042/bj0320494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DENT C. E., PHILPOT G. R. Xanthinuria, an inborn error (or deviation) of metabolism. Lancet. 1954 Jan 23;266(6804):182–185. doi: 10.1016/s0140-6736(54)91257-x. [DOI] [PubMed] [Google Scholar]
  7. DICKINSON C. J., SMELLIE J. M. Xanthinuria. Br Med J. 1959 Dec 5;2(5161):1217–1221. doi: 10.1136/bmj.2.5161.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dixon M. Studies on Xanthine Oxidase: The Specificity of the System. Biochem J. 1926;20(4):703–718. doi: 10.1042/bj0200703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ENGELMAN K., WATTS R. W., KLINENBERG J. R., SJOERDSMA A., SEEGMILLER J. E. CLINICAL, PHYSIOLOGICAL AND BIOCHEMICAL STUDIES OF A PATIENT WITH XANTHINURIA AND PHEOCHROMOCYTOMA. Am J Med. 1964 Dec;37:839–861. doi: 10.1016/0002-9343(64)90128-7. [DOI] [PubMed] [Google Scholar]
  10. GOLDFINGER S., KLINENBERG J. R., SEEGMILLER J. E. THE RENAL EXCRETION OF OXYPURINES. J Clin Invest. 1965 Apr;44:623–628. doi: 10.1172/JCI105175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. GOLDTHWAIT D. A., GREENBERG G. R., PEABODY R. A. The involvement of 5-phosphoribosylamine in the biosynthesis of glycinamide ribotide. Biochim Biophys Acta. 1955 Sep;18(1):148–149. doi: 10.1016/0006-3002(55)90026-3. [DOI] [PubMed] [Google Scholar]
  12. GOTS J. S., GOLDSTEIN J. Specific action of adenine as a feedback inhibitor of purine biosynthesis. Science. 1959 Sep 11;130(3376):622–623. doi: 10.1126/science.130.3376.622. [DOI] [PubMed] [Google Scholar]
  13. GOTS J. S. Purine metabolism in bacteria. V. Feed-back inhibition. J Biol Chem. 1957 Sep;228(1):57–66. [PubMed] [Google Scholar]
  14. HALL A. P., HOLLOWAY V. P., SCOTT J. T. 4-HYDROXYPYRAZOLO (3,4-D) PYRIMIDINE (HPP) IN THE TREATMENT OF GOUT: PRELIMINARY OBSERVATIONS. Ann Rheum Dis. 1964 Nov;23:439–446. doi: 10.1136/ard.23.6.439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HENDERSON J. F. Feedback inhibition of purine biosynthesis in ascites tumor cells. J Biol Chem. 1962 Aug;237:2631–2635. [PubMed] [Google Scholar]
  16. HURST V., GROSSMAN M., SUTTER V. L., FENNELL J. XANTHINE OXIDASE AND IRON. N Engl J Med. 1964 Mar 5;270:534–536. doi: 10.1056/NEJM196403052701020. [DOI] [PubMed] [Google Scholar]
  17. JONES O. W., Jr, ASHTON D. M., WYNGAARDEN J. B. Accelerated turnover of phosphoribosylpyrophosphate, a purine nucleotide precursor, in certain gouty subjects. J Clin Invest. 1962 Sep;41:1805–1815. doi: 10.1172/JCI104638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. KLENOW H. The enzymic oxidation and assay of adenine. Biochem J. 1952 Jan;50(3):404–407. doi: 10.1042/bj0500404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. KLINENBERG J. R., GOLDFINGER S. E., SEEGMILLER J. E. THE EFFECTIVENESS OF THE XANTHINE OXIDASE INHIBITOR ALLOPURINOL IN THE TREATMENT OF GOUT. Ann Intern Med. 1965 Apr;62:639–647. doi: 10.7326/0003-4819-62-4-639. [DOI] [PubMed] [Google Scholar]
  20. MAGER J., MAGASANIK B. Guanosine 5'-phosphate reductase and its role in the interconversion of purine nucleotides. J Biol Chem. 1960 May;235:1474–1478. [PubMed] [Google Scholar]
  21. MCCOLLISTER R. J., GILBERT W. R., Jr, ASHTON D. M., WYNGAARDEN J. B. PSEUDOFEEDBACK INHIBITION OF PURINE SYNTHESIS BY 6-MERCAPTOPURINE RIBONUCLEOTIDE AND OTHER PURINE ANALOGUES. J Biol Chem. 1964 May;239:1560–1563. [PubMed] [Google Scholar]
  22. POMALES R., BIEBER S., FRIEDMAN R., HITCHINGS G. H. Augmentation of the incorporation of hypoxanthine into nucleic acids by the administration of an inhibitor of xanthine oxidase. Biochim Biophys Acta. 1963 May 28;72:119–120. [PubMed] [Google Scholar]
  23. PRAETORIUS E., KIRK J. E. Hypouricemia: with evidence for tubular elimination of uric acid. J Lab Clin Med. 1950 Jun;35(6):865–868. [PubMed] [Google Scholar]
  24. SEEGMILLER J. E., GRAYZEL A. I., LASTER L., LIDDLE L. Uric acid production in gout. J Clin Invest. 1961 Jul;40:1304–1314. doi: 10.1172/JCI104360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. SEEGMILLER J. E., LASTER L., STETTEN D., Jr Incorporation of 4-amino-5-imidazolecarboxamide-4-C13 into uric acid in the normal human. J Biol Chem. 1955 Oct;216(2):653–662. [PubMed] [Google Scholar]
  26. VILLELA G. G., MITIDIERI E., AFFONSO O. R. Intracellular distribution of xanthine oxidase in the rat liver. Nature. 1955 Jun 18;175(4468):1087–1087. doi: 10.1038/1751087a0. [DOI] [PubMed] [Google Scholar]
  27. WATTS R. W., ENGELMAN K., KLINENBERG J. R., SEEGMILLER J. E., SJOERDSMA A. ENZYME DEFECT IN A CASE OF XANTHINURIA. Nature. 1964 Jan 25;201:395–396. doi: 10.1038/201395a0. [DOI] [PubMed] [Google Scholar]
  28. WYNGAARDEN J. B., ASHTON D. M. The regulation of activity of phosphoribosyl-pyrophosphate amidotransferase by purine ribonacleotides: a potential feedback control of purine biosyntoesis. J Biol Chem. 1959 Jun;234(6):1492–1496. [PubMed] [Google Scholar]
  29. WYNGAARDEN J. B., RUNDLES R. W., METZ E. N. ALLOPURNOL IN THE TREATMENT OF GOUT. Ann Intern Med. 1965 Apr;62:842–847. doi: 10.7326/0003-4819-62-4-842. [DOI] [PubMed] [Google Scholar]
  30. WYNGAARDEN J. B., SEEGMILLER J. E., LASTER L., BLAIR A. E. Utilization of hypoxanthine, adenine and 4-amino-5-imidazole-carboxamide for uric acid synthesis in man. Metabolism. 1959 Jul 1;8(4 Pt 1):455–464. [PubMed] [Google Scholar]
  31. Watts R. W., Watkins P. J., Matthias J. Q., Gibbs D. A. Allopurinal and acute uric acid nephropathy. Br Med J. 1966 Jan 22;1(5481):205–208. doi: 10.1136/bmj.1.5481.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Watts R. W., Watts J. E., Seegmiller J. E. Xanthine oxidase activity in human tissues and its inhibition by allopurinol (4-hydroxypyrazolo[3,4-d] pyrimidine). J Lab Clin Med. 1965 Oct;66(4):688–697. [PubMed] [Google Scholar]
  33. YUE T. F., GUTMAN A. B. EFFECT OF ALLOPURINOL (4-HYDROXYPYRAZOLO-(3,4-D)PYRIMIDINE) ON SERUM AND URINARY URIC ACID IN PRIMARY AND SECONDARY GOUT. Am J Med. 1964 Dec;37:885–898. doi: 10.1016/0002-9343(64)90131-7. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES